Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Elongin C pseudogene 18 (ELOCP18) is annotated as a processed pseudogene located at chromosome 1p31.3, spanning base pairs 68375327–68375663 on the human genome[2][3][4]. It is derived from the Elongin C gene, which encodes a subunit of the transcription elongation factor B (SIII) complex that regulates RNA polymerase II, but ELOCP18 itself does not encode a functional protein. There are no reported biological functions, disease associations, or known mechanisms of action for drugs, as ELOCP18 is not biologically active. Its nomenclature reflects its origin from the elongin C gene family but does not imply functional activity or therapeutic relevance[4]. If you are seeking information for a druggable target, ELOCP18 is not considered valid; the canonical protein-coding target would be "Elongin C" (abbreviated as ELOC), a legitimate component of the transcription elongation machinery and E3 ubiquitin ligase complexes[1][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elongin C pseudogene 18 (ELOCP18).